Continue to Site »
Site will load in 15 seconds

MedCana Subsidiary in Colombia Enters Negotiations With Australian Firm for Pharma Cannabis Supply

The company is poised to enter into a supply agreement with $1.2 million to $2.4 million annually.


Tony lange Cbt Headshot

AUSTIN, Texas, Oct. 16, 2024 – PRESS RELEASE – MedCana, a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, has entered negotiations with an Australian pharmaceutical firm to supply medical-grade cannabis through one of its subsidiaries in Colombia.

The agreement is projected to provide between $100,000 to $200,000 in monthly revenue once operations begin.

"This agreement represents a pivotal moment for MedCana as we continue expanding globally to meet the increasing demand for pharmaceutical-grade cannabis,” MedCana CEO Jose Gabriel Diaz said. 

Page 1 of 637
Next Page